161 related articles for article (PubMed ID: 29622903)
21. Prostate cancer screening in Tyrol, Austria: experience and results.
Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
Eur Urol; 1999; 35(5-6):523-38. PubMed ID: 10325519
[TBL] [Abstract][Full Text] [Related]
22. Enhanced expression of prostate-specific antigen in the transition zone of the prostate. A characterization following prostatectomy for benign hyperplasia.
Recker F; Kwiatkowski MK; Pettersson K; Piironen T; Lümmen G; Huber A; Tscholl R
Eur Urol; 1998; 33(6):549-55. PubMed ID: 9743696
[TBL] [Abstract][Full Text] [Related]
23. Carcinoma of prostate in clinically benign enlarged gland.
Khan IA; Nasir M; Akbar M; Khattak IU; Khan AN; Jan A; Asif S; Zia-ur-Rehman
J Ayub Med Coll Abbottabad; 2008; 20(2):90-2. PubMed ID: 19385466
[TBL] [Abstract][Full Text] [Related]
24. Incidental prostatic cancer: repeat TURP or biopsy?
Martino P; Palazzo S; Battaglia M; Lucarelli G; Selvaggi FP
Urol Int; 2004; 73(3):193-7. PubMed ID: 15539835
[TBL] [Abstract][Full Text] [Related]
25. [Clinicopathological study of incidental cancer prostate in patients undergoing surgery for symptomatic diagnosis of BPH].
Fernández Rosado E; Gómez Veiga F; Alvarez Castelo L; Ruibal Moldes M; Chantada Abal V; González Martín M
Actas Urol Esp; 2006 Jan; 30(1):33-7. PubMed ID: 16703727
[TBL] [Abstract][Full Text] [Related]
26. Standard surgical treatment for benign prostatic hyperplasia is safe for patients over 75 years: analysis of 100 cases from a high-volume urologic center.
Marmiroli R; Antunes AA; Reis ST; Nakano E; Srougi M
Clinics (Sao Paulo); 2012 Dec; 67(12):1415-8. PubMed ID: 23295595
[TBL] [Abstract][Full Text] [Related]
27. Radical prostatectomy for incidental (stage T1a-T1b) prostate cancer: analysis of predictors for residual disease and biochemical recurrence.
Capitanio U; Scattoni V; Freschi M; Briganti A; Salonia A; Gallina A; Colombo R; Karakiewicz PI; Rigatti P; Montorsi F
Eur Urol; 2008 Jul; 54(1):118-25. PubMed ID: 18314255
[TBL] [Abstract][Full Text] [Related]
28. Outcome of radical prostatectomy for incidental carcinoma of the prostate.
Melchior S; Hadaschik B; Thüroff S; Thomas C; Gillitzer R; Thüroff J
BJU Int; 2009 Jun; 103(11):1478-81. PubMed ID: 19076134
[TBL] [Abstract][Full Text] [Related]
29. Coexisting prostate cancer found at the time of holmium laser enucleation of the prostate for benign prostatic hyperplasia: predicting its presence and grade in analyzed tissue.
Bhojani N; Boris RS; Monn MF; Mandeville JA; Lingeman JE
J Endourol; 2015 Jan; 29(1):41-6. PubMed ID: 25046691
[TBL] [Abstract][Full Text] [Related]
30. [Incidental prostatic cancer].
Herranz Amo F; Díez Cordero JM; Verdú Tartajo F; Leal Hernández F; Bielsa Carrillo A; García Burgos J; Subirá Ríos D
Actas Urol Esp; 1999; 23(10):848-52. PubMed ID: 10670126
[TBL] [Abstract][Full Text] [Related]
31. [Transurethral resection of the prostatic gland (TUR-P) and incidental carcinoma].
Asakawa M; Yasumoto R; Kamizuru M; Maekawa M
Hinyokika Kiyo; 1988 Jun; 34(6):1003-5. PubMed ID: 2464913
[TBL] [Abstract][Full Text] [Related]
32. [Prostate cancer after prostatectomy for benign prostatic hyperplasia].
Hua L; Zhang J; Wu H; Sui Y; Zhang W; Qian L; Wang Z
Zhonghua Nan Ke Xue; 2004 Aug; 10(8):612-3. PubMed ID: 15362527
[TBL] [Abstract][Full Text] [Related]
33. When should we expect no residual tumor (pT0) once we submit incidental T1a-b prostate cancers to radical prostatectomy?
Capitanio U; Briganti A; Suardi N; Gallina A; Salonia A; Freschi M; Rigatti P; Montorsi F
Int J Urol; 2011 Feb; 18(2):148-53. PubMed ID: 21198944
[TBL] [Abstract][Full Text] [Related]
34. Early detection of prostate cancer in men with prostatism and intermediate prostate-specific antigen levels.
Schmid HP; Ravery V; Billebaud T; Toublanc M; Boccon-Gibod LA; Hermieu JF; Delmas V; Boccon-Gibod L
Urology; 1996 May; 47(5):699-703. PubMed ID: 8650868
[TBL] [Abstract][Full Text] [Related]
35. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
36. [Prostatic cancer developing after transurethral resection of the prostate for benign prostatic hyperplasia].
Tanaka Y; Aoyama H; Momose H; Ono T; Samma S; Tanaka N; Akiyama T; Tani Y; Masuda Y; Matsuki H; Tani M; Tanaka M
Hinyokika Kiyo; 2001 Jan; 47(1):11-4. PubMed ID: 11235214
[TBL] [Abstract][Full Text] [Related]
37. Prostate specific antigen cannot distinguish stage T1a (A1) prostate cancer from benign prostatic hyperplasia.
Monda JM; Barry MJ; Oesterling JE
J Urol; 1994 May; 151(5):1291-5. PubMed ID: 7512660
[TBL] [Abstract][Full Text] [Related]
38. Immediate radical prostatectomy in patients with atypical small acinar proliferation. Over treatment?
Brausi M; Castagnetti G; Dotti A; De Luca G; Olmi R; Cesinaro AM
J Urol; 2004 Sep; 172(3):906-8; discussion 908-9. PubMed ID: 15310995
[TBL] [Abstract][Full Text] [Related]
39. Serum prostate specific antigen levels after transurethral resection of prostate: a longitudinal characterization in men with benign prostatic hyperplasia.
Marks LS; Dorey FJ; Rhodes T; Shery ED; Rittenhouse H; Partin AW; deKernion JB
J Urol; 1996 Sep; 156(3):1035-9. PubMed ID: 8709302
[TBL] [Abstract][Full Text] [Related]
40. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia.
Furuya Y; Akakura K; Tobe T; Ichikawa T; Igarashi T; Ito H
Int J Urol; 2000 Dec; 7(12):447-51. PubMed ID: 11168683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
